Last Updated: November 9, 2026

Acella Company Profile

« Back to Dashboard

What is the competitive landscape for ACELLA

ACELLA has thirteen approved drugs.

Summary for Acella

US Patents:	0
Tradenames:	12
Ingredients:	12
NDAs:	13
Patent Litigation for Acella:	See patent lawsuits for Acella

Drugs and US Patents for Acella

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Acella Pharms Llc	GABAPENTIN	gabapentin	SOLUTION;ORAL	076403-001	May 1, 2012	AA	RX	No	No		⤷ Start Trial				⤷ Start Trial
Acella	BENZONATATE	benzonatate	CAPSULE;ORAL	091310-001	Jan 16, 2015		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Acella	LACOSAMIDE	lacosamide	SOLUTION;INTRAVENOUS	218464-001	Nov 14, 2024	AP	RX	No	No		⤷ Start Trial				⤷ Start Trial
Acella	HYDROCODONE BITARTRATE AND CHLORPHENIRAMINE MALEATE	chlorpheniramine maleate; hydrocodone bitartrate	SOLUTION;ORAL	206891-001	Jun 9, 2017		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Acella	PHENYTOIN SODIUM	phenytoin sodium	INJECTABLE;INJECTION	040573-001	Sep 13, 2006	AP	RX	No	No		⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.